Cargando…
Applications of iPSC-derived beta cells from patients with diabetes
Improved stem cell-derived pancreatic islet (SC-islet) differentiation protocols robustly generate insulin-secreting β cells from patient induced pluripotent stem cells (iPSCs). These advances are enabling in vitro disease modeling studies and the development of an autologous diabetes cell replaceme...
Autores principales: | Maxwell, Kristina G., Millman, Jeffrey R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080107/ https://www.ncbi.nlm.nih.gov/pubmed/33948571 http://dx.doi.org/10.1016/j.xcrm.2021.100238 |
Ejemplares similares
-
Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome
por: Kitamura, Rie Asada, et al.
Publicado: (2022) -
Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020) -
Generation and manipulation of human iPSC-derived platelets
por: Sugimoto, Naoshi, et al.
Publicado: (2021) -
Modeling Alzheimer’s disease with iPSC-derived brain cells
por: Penney, Jay, et al.
Publicado: (2019) -
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023)